Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CXT | DGII |
|---|---|---|
| Price | $49.16 | $74.56 |
| Change today | ▲ 0.78% | ▼ 1.39% |
| Market cap | $2.83B | $2.83B |
| Return, 3 months | -1.1% | +6.3% |
| Return, year to date | +5.7% | +72.2% |
| Return, 1 year | -26.1% | +102.8% |
| P/E (TTM) | 20.3 | 59.2 |
| P/B | 2.2 | 4.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 1.42% | – |
| Revenue growth (YoY, latest qtr) | – | +29.0% |
| Net profit growth (YoY) | – | +53.7% |
| Gross margin | – | 64.8% |
| Operating margin | – | 16.5% |
| Net margin | – | 11.4% |
| Return on equity | – | – |
| Analyst target vs. price | +39.5% | +14.5% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 53 | 51 |
| 30-day volatility | 34.8% | 35.0% |
| Max drawdown, 1 year | -47.0% | -21.8% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
